Expanse Medical Opens Providence Facility with Support from Rhode Island Life Science Hub
Expanse Medical announced it will open a new facility in Providence, Rhode Island, with support from the Rhode Island Life Science Hub, according to a press release. The new site will serve as the company’s East Coast base and as the launchpad for Valorian Medical Technologies, a new venture focused on men’s health innovation.
The Providence facility will connect engineering talent, clinicians, and investors, contributing to Rhode Island’s growing life sciences community. Valorian will leverage Expanse’s product development and clinical capabilities to develop medical technologies addressing men’s health conditions, including erectile dysfunction.
The expansion follows the launch of FlowPhysix, another Expanse portfolio company based in Austin, Texas, which commercialized the FDA-cleared FLOWRUNNER Aspiration System for treating blood clots. Expanse’s new Providence presence aims to strengthen collaboration with innovators and accelerate medical device development across the East Coast.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 29 University Medical Center Göttingen Adopts MDClone Clinical Data Platform Sep 29 LUNGevity Awards $2 Million for Lung Nodule Risk Studies Sep 28 Deep Longevity to Launch Accrua Telehealth Platform in US Sep 28 United Imaging Intelligence Releases Medical Video AI Framework Sep 28 Orca Dental AI Brings CephX Imaging Tools to Planet DDS Cloud 9Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Deep Longevity to Launch Accrua Telehealth Platform in US
Rutgers and RWJBarnabas Health Launch AWS Health Innovation Hub
Thyme Care Raises Over $125 Million and Forms Thyme Companies
Basecamp Research Raises $140 Million for AI Designed Therapeutics
UrgentIQ Raises $15 Million for AI Clinical Workflows
Daily AI Brief: the AI news that matters, in your inbox.